Amgen Inc. Accounts Payable
Amgen Inc. (AMGN) had Accounts Payable of $2.87 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Payable, Current $2.87B.
- 2026-03-31: Accounts Payable, Current $2.94B.
- 2025-12-31: Accounts Payable, Current $2.37B.
- 2025-09-30: Accounts Payable, Current $2.84B.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.87B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $2.94B 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $2.37B 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $2.84B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $3.01B 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $2.41B 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $1.91B 10-K · filed 2026-02-13 | |
| 2024-09-30 | $2.15B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $2.27B 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $1.63B 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $1.59B 10-K · filed 2025-02-14 | |
| 2023-09-30 | $1.36B 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $1.21B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $1.32B 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $1.57B 10-K · filed 2024-02-14 | |
| 2022-09-30 | $1.20B 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $1.26B 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $1.40B 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $1.37B 10-K · filed 2023-02-09 | |
| 2021-09-30 | $1.17B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $1.28B 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $1.40B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $1.42B 10-K · filed 2022-02-16 | |
| 2020-09-30 | $1.16B 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $1.15B 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $1.34B 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $1.37B 10-K · filed 2021-02-09 | |
| 2019-09-30 | $1.00B 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $1.00B 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $1.09B 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $1.21B 10-K · filed 2020-02-12 | |
| 2018-09-30 | $1.04B 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $1.03B 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $1.09B 10-Q · filed 2018-04-25 | |
| 2017-12-31 | $1.35B 10-K · filed 2019-02-13 | |
| 2017-09-30 | $879.00M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $883.00M 10-Q · filed 2017-07-26 | |
| 2017-03-31 | $902.00M 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $917.00M 10-K · filed 2018-02-13 | |
| 2016-09-30 | $825.00M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $870.00M 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $818.00M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $965.00M 10-K · filed 2017-02-14 | |
| 2015-09-30 | $1.07B 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $934.00M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $888.00M 10-Q · filed 2015-04-27 | |
| 2014-12-31 | $995.00M 8-K · filed 2016-10-31 | $1.21B 10-K · filed 2015-02-19 |
| 2014-09-30 | $955.00M 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $982.00M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $949.00M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $787.00M 10-K · filed 2015-02-19 | |
| 2013-09-30 | $895.00M 10-Q · filed 2013-10-29 | |
| 2013-06-30 | $1.01B 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $940.00M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $905.00M 10-K · filed 2014-02-24 | |
| 2012-09-30 | $878.00M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $884.00M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $891.00M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $642.00M 10-K · filed 2013-02-27 | |
| 2011-09-30 | $734.00M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $870.00M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $832.00M 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $716.00M 10-K · filed 2012-02-29 | |
| 2010-09-30 | $759.00M 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $722.00M 10-Q · filed 2010-08-09 | |
| 2010-03-31 | $882.00M 10-Q · filed 2010-05-07 | |
| 2009-12-31 | $574.00M 10-K · filed 2011-02-25 | |
| 2009-09-30 | $613.00M 10-Q · filed 2009-11-06 | |
| 2008-12-31 | $504.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |